The direct-to-consumer genetic testing market is estimated to reach US$4843.4 million; Growing at a CAGR of 11.4% by the end of 2033 expected | Future Market Insights, Inc.

The direct-to-consumer genetic testing market is expected to see significant demand driven primarily by ancestry testing, which comprises a major segment of direct-to-consumer genetic testing (DTC-GT). These tests are sold directly to people without the involvement of healthcare professionals or health insurers.

NEWARK, Del, July 10, 2023 (GLOBE NEWSWIRE) — The global direct-to-consumer genetic testing market was $1,485.1 million in 2022 and is estimated to reach $1,645.5 million in 2023. Future Market Insights mentioned in its report that the smart farming solutions market will expand at a CAGR of 11.40% between 2023 and 2033, totaling approximately $4,843.4 million by 2033.

The increase in income level in developing countries has further anticipated the growth of the direct-to-consumer (DTC) genetic testing market, where the rising cost of DTC genetic testing is further projected to boost the growth of direct -to-consumer (DTC) genetic testing market over time period.

Prey You Exclusive Report: Unveiling the Spectacular Growth of the Direct-to-consumer genetic testing market: https://www.futuremarketinsights.com/reports/sample/rep-gb-15137

Key points from thAND Market:

• The global direct-to-consumer genetic testing market is projected to grow at a CAGR of 11.2% from 2022 to 2032 and is likely to reach USD 4.0 billion in 2032.

• The global direct-to-consumer genetic testing (DTC-GT) market grew at a CAGR of 9.8% between 2017 and 2022.

• The direct-to-consumer genetic testing (DTC-GT) market grew at a CAGR of 15.6% and accounted for approximately USD 8.0 billion of the global genetic testing market in 2021.

• North America holds an important share of the market with a value share of 48.2%.

• The United States has a market share of direct-to-consumer genetic testing of approximately 42.9%.

• Japan is said to hold a major share of the market with a value share of 6.3%.

• The Chinese market is said to grow at a CAGR of 12.7% in East Asia.

• India uses genetic screening services growing at a CAGR of 15.3%.

• The Australian market is expected to expand at a CAGR of 8.9%.

• Germany is expected to exhibit a CAGR of nearly 7.1% in Europe, where it holds 32.7% of the market share.

• The UK is likely to grow at a CAGR of 11.8%.

• The ancestry testing segment has shown high growth with a CAGR of 10.9%, with an expected share of around 38.2% in the global market in the same year.

• The single nucleotide polymorphism chips segment held a market share of approximately 64.5% and is expected to show gradual growth over the forecast period.

• The saliva segment had a direct-to-consumer genetic testing market share of 67.0%.

• The retail segment held the highest share of the direct-to-consumer genetic testing market, at nearly 79.5%.

The story continues

Using genetic vendors to assert kinship relationships acts as one of the biggest opportunities in direct-to-consumer genetic test manufacturers, – comments an analyst from Future Market Insights (IMF).

Our analyst is available to help you with any questions you may have: https://www.futuremarketinsights.com/ask-question/rep-gb-15137

Competitive landscape:

Some of the prominent players in the global market are:

• 23 and I

• Ancestry DNA

• Color Genomics, Inc.

• Gene Technology (EasyDNA)

• Complete Genomes Corporation, Inc.

• Propeller OpCo LLC

• IDENTIGENE, LLC/DNA Diagnostic Center

• Living DNA Ltd

• MyHeritage Ltd

• Prenetics Limited

• Family tree DNA

• Genetics of interleukin/orig3n

• Councilyl/Myriad Genetics, Inc.

• Genetic truth

• Brilliant genomics

Some of the recent industry developments in the global direct-to-consumer genetic testing market are:

• In May 2023, 23andMe is offering a mine of insight into your deepest genetics and ancestry where this top-notch DNA testing service also provides checkups for genetic health risks and your carrier status for many conditions.

Additional valuable information available:

Future Market Insights offers an unbiased analysis of the direct-to-consumer genetic testing market by providing historical data from 2017 to 2022 and forward-looking statistics from 2023 to 2033.

To understand the opportunities in the direct-to-consumer genetic testing market it is segmented on the main by product: (pharmacogenetics tests, carrier screening tests, genetic health risk tests (GHR), cancer susceptibility tests, of low-risk general well-being, ancestry testing), by technology: (single nucleotide polymorphism chips, whole genome sequencing), by sample: (saliva, urine, blood), by sales channel: [(Institutional Sales- Hospitals, Specialty Clinics, Diagnostic Laboratories, Others), (Retail Sales- Retail Pharmacies, Online Sales)]By Region: (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa)

Fine-tune your strategy: Get personalized analytics to stay ahead of the curve Direct-to-consumer genetic testing market: https://www.futuremarketinsights.com/customization-available/rep-gb-15137

Market Outlook by Categorization:

By product:

• Pharmacogenetics test

• Carrier screening test

• Genetic health risk test (GHR).

• Cancer predisposition test

• Low-risk general well-being test

• Ancestry test

By technology:

For sample:

By sales channel:

• Institutional sales

  • hospitals

  • Special Clinics

  • Diagnostic laboratories

  • Others

• Retail Sales

  • Retail pharmacies

  • Online sales

By region:

• North America

• Latin America

• Western Europe

• Eastern Europe

• South Asia and the Pacific

• East Asia

• Middle East and Africa

Take this opportunity for a detailed market Intel: Buy now to access: https://www.futuremarketinsights.com/checkout/15137

Learn about the Healthcare division of Future Market Insights (IMF):

Future Market Insights healthcare team delivers expert analysis, time-efficient research, and strategy recommendations to deliver authentic insights and accurate results to help clients worldwide. With a repertoire of over 100 reports and over 1 million data points, the team has lucidly analyzed the industry in over 50 countries for over a decade. The team provides a brief analysis of key trends, including the competitive landscape, profit margin and research development efforts.

ANDxplore IMF ongoing Coverage ongoing on Healthcare market Domain:

Osteotomy Plates Market Size: The Osteotomy Plates market is projected to be valued at USD 615.5 million by 2033, compared to USD 375.5 million in 2023, at a CAGR of 5.1% during the forecast period.

Osteonecrosis Treatment Market Share: The market size of osteonecrosis treatment is projected to be valued at USD 268.2 million in 2023 and is expected to rise to USD 434.0 million by 2033.

Neuro Immunoassays Market Trends: The Neuro Immunoassays market is projected to be valued at USD 5,303.1 Million by 2033, compared to USD 2,616.1 Million in 2023, at a CAGR of 7.3% during the forecast period.

Veterinary Computed Tomography Scanners Market Growth: The Veterinary Computed Tomography Scanners Market is currently valued at US$173.7 Million in 2022, growing at a constant CAGR of 6.8% till 2033. It is forecasted to the market will exceed the value of revenues by 355.3 million dollars by 2033 .

Veterinary Insoles and Implants Market Demand: According to the latest report released by Future Market Insights (FMI), the market size of Veterinary Insoles and Implants is projected to exceed USD 66.5 million in 2023. It is forecasted that the market for veterinary insoles and prosthetics is expected to reach US $164.2 million in 2033 and is projected to thrive at a CAGR of 9.5%

Market Opportunity for Veterinary Blood Glucose Meters: The market size for Veterinary blood glucose meters is projected to be valued at US$351.3 million in 2023, and is projected to grow to US$574.9 million by 2033. The sales of veterinary glucometers are expected to expand at a significant CAGR of 5.0% during the forecast period.

Visual Electrophysiology Market Overview: The Visual Electrophysiology market is projected to flourish at a constant CAGR of 7.0% between 2023 and 2033. The market is projected to hold a market share of 458.9 million dollars by 2033, while the market is likely to reach a value of US$234.1 million in 2023.

Portable Anesthesia Systems Market Strategies: The global Portable Anesthesia Systems market is projected to accumulate a value of USD 493.6 million by the end of 2023. During the forecast period 2023 to 2033, it was projected to market at a CAGR of 6.6%, with an expected closing value of $933.4 million.

SPECT Scanning Services Market Forecast: The global SPECT scanning services market is estimated to secure a valuation of USD 2.1 billion in 2022. The global market is expected to expand at an average CAGR of 8.5 % and will reach $4.7 billion by 2032.

Sensor Patch Market Development: The global Sensor Patch market reaches a valuation of USD 3.1 billion in 2023, with a projected CAGR of 39.5% from 2023 to 2033. By 2033, the market will reach 85.8 billion dollars.

Future Markets Information (IMF)

Future Market Insights, Inc. (ESOMAR-certified, Stevie Award-winning market research organization and member of the Greater New York Chamber of Commerce) provides insights into the factors driving increased demand in the market. It describes opportunities that will drive market growth across various segments on the basis of Source, Application, Sales Channel and End Use over next 10 years.

Contact us:

Future Market Insight Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For sales inquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | Youtube